Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mebendazole Polymorphs for Hookworm Infection
NCT01350271Phase 3Completed
- Sponsor
- University of Kelaniya
- Start
- May 2011
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mebendazole in Necator americanus infection (3 arms), sponsored by University of Kelaniya. Primary endpoint: Cure Rate at 2 weeks. Started May 2011; status: completed.
02
Drugs
mebendazole
03
Conditions
Necator americanus infection
Beyond the preview
Go deeper on NCT01350271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01350271.